Skip to content

Clinical trials

Phase 2/3 Pancreatic Diseases trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pancreatic Diseases Phase: Phase 2/3 Clear all

4 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20151
20191
20201
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed1
Recruiting1
Suspended1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Cancer Research UK1
Mayo Clinic1
University of Alberta1
University of Washington, the Collaborative Health Studies Coordinating Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pancreatic Diseases4
Carcinoma, Non-Small-Cell Lung1
Colorectal Neoplasms1
Cystic Fibrosis1
Digestive System Diseases1
Erdheim-Chester Disease1
Gastrointestinal Neoplasms1
Genetic Diseases, Inborn1
Glioma1
Hematologic Neoplasms1

Trials

Showing 1 to 4 of 4. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.